GGrantIndex
Sort

21,453 grants matching tuberculosis

Genetic and hormonal mechanisms mediating sex differences in TB and TB-HIV

$813,838
William Ramses Bishai · Johns Hopkins University · R37 · FY2023 · AI

Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity

$813,838
William Ramses Bishai · Johns Hopkins University · R01 · FY2023 · AI

Exploration, conservation, and development of marine bi*

$813,774
Mark E Hay · Georgia Institute Of Technology · U01 · FY2006 · TW

ULTIMATE

$813,477
Reinout Van Crevel · Stichting Radboud Universitair Medisch Centrum I.O. · R01 · FY2023 · AI

METABOLIC ALDEHYDES AS IMMUNE EFFECTORS AGAINST TUBERCULOSIS

$813,454
Katerina Heran Darwin · New York University School Of Medicine · R01 · FY2021 · AI

Evaluating human T cells specific for Mycobacterium tuberculosis antigens that are processed and presented by infected macrophages

$813,450
Stephen Matthew Carpenter · Case Western Reserve University · R01 · FY2025 · AI

Longitudinal Studies of HIV-Associated Lung Infections and Complications

$813,438
Kristina Anne Crothers · Yale University · R01 · FY2007 · HL

Unraveling the spectrum of intrabacterial amide hydrolysis to develop new classes of pyrazinoic acid prodrugs against pyrazinamide resistant Mycobacterium tuberculosis

$813,373
David Alland · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI

Conservation and Sustainable Use of Biodiversity in PNG

$813,034
Louis R Barrows · University Of Utah · U01 · FY2013 · TW

Host factors, inflammation, and HIV associated TB

$812,899
Anne Goldfeld · Boston Children'S Hospital · R56 · FY2015 · HL

Genetic, Metabolic and Regulatory Control of MIC and Relapse in M. tuberculosis

$812,613
David R Sherman · University Of Washington · R01 · FY2024 · AI

Genetic, Metabolic and Regulatory Control of MIC and Relapse in M. tuberculosis

$812,613
David R Sherman · University Of Washington · R01 · FY2023 · AI

A Cytomegalovirus-based Vaccine Targeting the Pre-erythrocytic Stage of Malaria

$812,475
Klaus J Frueh · Oregon Health & Science University · R01 · FY2017 · AI

Modeling Core

$812,406
Nitin S Baliga · Seattle Biomedical Research Institute · U19 · FY2014 · AI

HIV/AIDS International Training Program

$812,312
Christopher C. Whalen · Case Western Reserve University · D43 · FY2008 · TW

Genetic, Metabolic and Regulatory Control of MIC and Relapse in M. tuberculosis

$812,257
David R Sherman · University Of Washington · R01 · FY2022 · AI

Genetic, Metabolic and Regulatory Control of MIC and Relapse in M. tuberculosis

$812,107
David R Sherman · University Of Washington · R01 · FY2021 · AI

Development of Novel Proteins Synthesis Inhibitors for MDR Tuberculosis

$811,999
Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2020 · AI

Video DOT and Economic Incentives to promote adherence to LTBI therapy

$811,650
Maunank Shah · Johns Hopkins University · R01 · FY2021 · AI

A Novel Th17-inducing Mucosal Vaccine for Tuberculosis

$811,554
Shabaana A. Khader · Washington University · R01 · FY2021 · AI

Intermembrane transport of lipids and metabolites by mycobacterial MmpL protein complexes

$811,396
Helen I. Zgurskaya · University Of Oklahoma · R01 · FY2025 · AI

Structure, function, and regulation of the bacterial transcription cycle

$811,237
Seth A Darst · Rockefeller University · R35 · FY2020 · GM

Structure, function, and regulation of the bacterial transcription cycle

$811,237
Seth A Darst · Rockefeller University · R35 · FY2017 · GM

Clinical And Therapeutic Studies Of Human Filariasis and Related Diseases

$811,167
Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

UCB/UCSF AIDS International Training and Research Program (AITRP)

$811,071
Arthur L. Reingold · University Of California Berkeley · D43 · FY2008 · TW